Impact of elotuzumab treatment on pain and health-related quality of life in patients with relapsed or refractory multiple myeloma: results from the ELOQUENT-2 study

Publisher:
Springer Nature America, Inc
Publication Type:
Journal Article
Citation:
Annals of Hematology, 2018, 97 (12), pp. 2455 - 2463
Issue Date:
2018-12
Metrics:
Full metadata record
Files in This Item:
Filename Description Size
Cella-2018-Impact-of-elotuzumab-treatment-on-p.pdfPublished Version586.05 kB
Adobe PDF
Please use this identifier to cite or link to this item: